March 6, 2026 Release Highlights Copied
Practice Insights is pleased to announce updates in the application to support the Merit-Based Incentive Payment System (MIPS), Advanced Care Planning (ACP), and Enhancing Oncology Model (EOM).
MIPS Quality Measures Dashboard
The MIPS Quality Measures Dashboard will be updated to reflect the following:
| Measure | Update | Practice Impact |
| MIPS 143: Pain Intensity Quantified | For 2026, it is no longer required for providers to assess pain during telehealth visits for patients undergoing radiation therapy. They are still required to assess pain during face-to-face visits. | Practices will notice a slight shift in their Denominator and/or Numerator. |
Advanced Care Planning Dashboards
The Advanced Care Planning Dashboard will be updated to reflect the following:
Starting Monday, March 9, 2026, the Advance Care Planning Performance and Advance Care Planning Activities dashboards will be updated with final data from Q4-2025.
EOM Performance Dashboard
Starting Monday, March 9, 2026, the EOM Performance Dashboard has been updated to decrease loading times.
Status of Dashboard Updates for 2026
CMS releases updates to the quality measure specifications annually for the MIPS program. These measure specifications have been reviewed, and Practice Insights is working on the required technical updates to align with the revised requirements. Ontada will continue to notify practices once measures have been updated based on the current 2026 requirements.
The following measures have been fully updated for the 2026 measure year:
| Measure Number | Description |
| MIPS Quality Measures Dashboard | |
| MIPS #001 | Diabetes Hemoglobin A1c (HbA1cc) Poor Control (>9%) (Inverse Measure) |
| MIPS #047 | Advance Care Plan |
| MIPS #143 | Pain Intensity Quantified |
| MIPS #226 | Tobacco Screening and Cessation |
| MIPS #236 | Controlling High Blood Pressure |
| MIPS #238 | Use of High-Risk Medications in Older Adults (Inverse Measure) |
| MIPS #462 | Bone Density Evaluation for Patients with Prostate Cancer and Receiving Androgen Deprivation Therapy |
| PIMSH #10 | Hepatitis B Serology Testing and Prophylactic Treatment Prior to Receiving Anti-CD20 Targeting Drugs |
| PIMSH #17 | Utilization of Prophylactic GCSF for Cancer Patients Receiving Low-Risk Chemotherapy (Inverse Measure) |